tiprankstipranks
Trending News
More News >

Christopher Starr Insider Profile

4 Followers
Christopher Starr, Director at Raptor Pharmaceutical Corp., holds 15.05K shares in Monopar Therapeutics Inc (Ticker: MNPR), holds 706.07K shares in Raptor Pharmaceutical Corp. (Ticker: RPTP). Most recently, Christopher Starr Sold ― shares of Monopar Therapeutics Inc on Jul 16, 2025 for an estimated value of 672.00K.
tipranks
Christopher Starr

Christopher Starr
Raptor Pharmaceutical Corp. (RPTP)
Director

Not Ranked
Christopher Starr has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$620K
100.00%
A breakdown of Christopher Starr's holdings

Insider Roles

Monopar Therapeutics Inc
(MNPR)
Director
Roles that Christopher Starr holds in companies

Most Profitable Insider Trade

Stock:
Monopar Therapeutics Inc
(MNPR)
Rating:Informative Sell
Date:Jul 16, 2025 - Today
Return:-9.40%
The most profitable trade made by Christopher Starr

Christopher Starr's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RPTP
Raptor Pharmaceutical Corp.
Jun 27, 2016
Uninformative Buy
$6.35M
Monopar Therapeutics Inc
Jul 16, 2025
Director
Informative Sell
672.00K
$619.88K
List of latest transactions for each holding click on a transaction to see Christopher Starr's performance on stock

Christopher Starr insider profile FAQ

What is the percentage of profitable transactions made by Christopher Starr?
The percentage of profitable transactions made by Christopher Starr is ―.
    What is the average return per transaction made by Christopher Starr?
    The average return per transaction made by Christopher Starr is ―.
      What stocks does Christopher Starr hold?
      Christopher Starr holds: RPTP, MNPR stocks.
        What was Christopher Starr’s latest transaction?
        Christopher Starr latest transaction was an Informative Sell of $672.00K.
          What was Christopher Starr's most profitable transaction?
          Christopher Starr’s most profitable transaction was an Informative Sell of MNPR stock on July 16, 2025. The return on the trade was -9.40%.
            What is Christopher Starr's role in Raptor Pharmaceutical Corp.?
            Christopher Starr's role in Raptor Pharmaceutical Corp. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.